查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1663542

灌注放射學市場，按檢測類型、按方式、按最終用途、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Perfusion Radiology Market, By Assay Type, By Modality, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年灌注放射學市場規模價值為 28.142 億美元，2025 年至 2032 年期間的複合年成長率為 4.50%。

灌注放射學市場-市場動態

心血管和神經系統疾病增加

由於生活方式改變和不良的飲食習慣導致心血管和神經系統疾病增多，灌注放射學市場正在成長。根據中風統計小組委員會和美國心臟協會統計委員會發布的統計數據，每年有 795,000 人心臟病發作。 2017年，這些數據被公佈。因此，政府資助的計劃、醫療機構和其他組織必須立即制定策略，提高對有助於監測進展和治療疾病的技術發展知識。透過使用精確的影像方法測量器官血流量，灌注放射學可以幫助醫生發現異常、追蹤疾病進程並評估治療效果。人們對精確​​和非侵入性診斷技術的需求日益成長，以治療複雜的神經和心血管問題，從而推動了灌注放射學的採用，從而推動了創新和市場擴張。

灌注放射學市場 - 關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 4.50%

根據檢測類型細分，心血管影像預計將在 2024 年佔據最大市場佔有率

根據最終用途細分，醫院將成為 2024 年的主要細分市場

從地區來看，北美是 2024 年最大的收入來源

灌注放射學市場-細分分析：

全球灌注放射學市場根據檢測類型、方式、最終用途和地區進行細分。

根據檢測類型，市場分為心血管成像、腦部影像和通氣成像。 2024 年，市場將由心血管影像類別主導，因為心血管疾病 (CVD) 在世界各地變得越來越普遍。由於電腦斷層掃描 (CT) 和磁振造影 (MRI) 等影像技術的發展，灌注放射學在識別和治療心臟問題方面變得更加準確和有效。此外，醫療成本的上漲以及早期診斷和治療意識的增強也推動了對心血管影像技術的需求。由於人工智慧（AI）的加入進一步提高了診斷精度，成像系統已成為臨床實踐中必不可少的一部分。

根據方式，市場分為磁振造影 (MRI)、核子醫學和電腦斷層掃描 (CT)。 2024 年，電腦斷層掃描 (CT) 類別因其廣泛的可用性、出色的診斷精度以及提供全面橫斷面影像的能力而佔據主導地位。它們對於治療中風和評估腦血流至關重要，低劑量 CT 等發展正在促進它們的使用。腫瘤學、神經病學和心血管護理都廣泛使用動脈自旋標記 (ASL) 和動態增強 (DCE) 成像等技術。磁振造影（MRI）由於其卓越的軟組織對比度、非侵入性能力和無輻射成像而變得越來越受歡迎。

灌注放射學市場-地理洞察

2024 年，北美在全球灌注放射學市場佔據主導地位。這種領導地位歸功於該地區對醫學研究的大力投資、神經和心血管疾病的高發性以及完善的醫療保健基礎設施。美國主要推動區域成長，因為其集中了西門子和通用電氣等主要市場參與者，並且大力採用先進的成像技術。優惠的報銷規定進一步促進了該地區灌注放射學市場的成長。

然而，在整個預測期內，預計歐洲地區的複合年成長率最快。德國、法國和英國憑藉其完善的醫療保健體系、廣泛使用尖端技術以及鼓勵早期疾病發現的政府計畫而處於領先地位。隨著歐洲人口老化以及癌症、中風等慢性疾病的發生率上升，對灌注放射學技術的需求越來越大。歐盟促進醫學研究和國際醫療保健合作的措施有助於推動灌注放射學市場的擴張。

灌注放射學市場-競爭格局：

在競爭激烈的灌注放射學市場中，多家競爭對手正在爭奪更大的佔有率，例如通用電氣公司、西門子醫療股份公司、Sonic Healthcare、InHealth Group、RadNet, Inc. 等。製藥公司、軟體解決方案提供者和醫療影像設備製造商是重要的產業參與者。為了提高市場地位，這些企業專注於研發、策略聯盟、併購和新產品引進。產品組合、技術發展、客戶服務、價格政策和品牌聲譽是市場競爭力的重要決定因素。為了滿足醫療保健提供者的獨特要求，改善患者護理並提高整體營運效率，市場參與者努力提供全面的灌注放射學解決方案。例如，2023年5月，Ion Beam Applications SA 在西班牙舉行的歐洲心血管成像協會（EACVI）會議期間介紹了一種基於PET心肌灌注成像的不同尋常的組合解決方案AKURACY。 IBA 是 EURONEXT 的成員，在放射性藥物生產解決方案和粒子加速器技術開發領域處於領先地位。

目錄

第 1 章：灌注放射學市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 灌注放射學市場片段（依檢測類型）
    • 灌注放射學市場片段（按方式）
    • 灌注放射學市場片段（依最終用途）
    • 灌注放射學市場片段（按國家/地區）
    • 灌注放射學市場片段（按地區）
  • 競爭洞察

第 3 章：灌注放射學主要市場趨勢

  • 灌注放射學市場促進因素
    • 市場促進因素的影響分析
  • 灌注放射學市場限制
    • 市場限制的影響分析
  • 灌注放射學市場機會
  • 灌注放射學市場未來趨勢

第 4 章：灌注放射學產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第 5 章：灌注放射學市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠肺炎疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長領域
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：灌注放射學市場格局

  • 灌注放射學市佔率分析，2024 年
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：灌注放射學市場 - 依檢測類型

  • 概述
    • 按檢測類型分類的細分市場佔有率分析
    • 心血管影像
    • 腦部影像
    • 通氣成像

第 8 章：灌注放射學市場 - 按方式

  • 概述
    • 按方式分類的細分市場佔有率分析
    • 磁振造影（MRI）
    • 核子醫學
    • 電腦斷層掃描 (CT)

第 9 章：灌注放射學市場 - 依最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 診斷實驗室
    • 其他

第 10 章：灌注放射學市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美灌注放射學主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按檢測類型）
    • 北美市場規模及預測（按方式）
    • 北美市場規模和預測，按最終用途
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲灌注放射學主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模及預測（按檢測類型）
    • 歐洲市場規模及預測（依方式）
    • 歐洲市場規模和預測，按最終用途
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區灌注放射學主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太市場規模及預測（依檢測類型）
    • 亞太市場規模及預測（依方式）
    • 亞太市場規模及預測（依最終用途分類）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲灌注放射學主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按檢測類型）
    • 拉丁美洲市場規模及預測（按方式）
    • 拉丁美洲市場規模及預測（依最終用途分類）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲灌注放射學主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按檢測類型）
    • 中東和非洲市場規模及預測（按方式）
    • 中東和非洲市場規模及預測（按最終用途分類）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 11 章：主要供應商分析-灌注放射學產業

  • 競爭儀錶板
  • 公司簡介
    • GENERAL ELECTRIC COMPANY
    • Siemens Healthineers AG
    • Sonic Healthcare
    • InHealth Group
    • RadNet, Inc.
    • Spectrum Health
    • Alliance HealthCare Services
    • Hologic Inc.
    • Koninklijke Philips NV
    • RamSoft, Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4697

REPORT HIGHLIGHT

Perfusion Radiology Market size was valued at US$ 2,814.2 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

Perfusion radiology is the study of blood flow patterns in particular bodily parts, organs, or tissues. It entails giving contrast agents, which improve blood vessel visibility and make it easier to see blood flow in real-time. Perfusion radiology allows radiologists to evaluate tissue viability, spot regions of decreased or increased blood flow, and spot anomalies. This diagnostic method is non-invasive and essential for offering important information about how different organs work physiologically. The growing prevalence of chronic diseases, the need for precise diagnostic methods, and improvements in imaging technology are all contributing to the significant rise of the global perfusion radiology market. New software programs and imaging modalities that improve the precision and effectiveness of perfusion radiology procedures are being introduced to the market. Furthermore, the market is expanding due to rising patient and healthcare professional awareness of the advantages of perfusion radiology. Nonetheless, various obstacles, like the high cost of equipment and restricted accessibility in underdeveloped nations, can somewhat impede the perfusion radiology market expansion.

Perfusion Radiology Market- Market Dynamics

Increase in cardiovascular and neurological conditions

The market for perfusion radiology is growing as a result of an increase in cardiovascular and neurological conditions brought on by altered lifestyles and poor eating habits. According to statistics issued by the Stroke Statistics Subcommittee and the American Heart Association Statistics Committee, 795,000 persons have a heart attack annually. In 2017, these figures were made public. Government-funded initiatives, medical facilities, and other organizations must, therefore, immediately devise strategies to raise knowledge of the technological developments that aid in monitoring progress and curing the illness. By using accurate imaging methods to measure organ blood flow, perfusion radiology helps doctors spot anomalies, track the course of diseases, and gauge how well treatments are working. Perfusion radiology adoption is being fueled by the increasing need for precise and non-invasive diagnostic techniques to treat complicated neurological and cardiovascular problems, which is propelling innovation and market expansion.

Perfusion Radiology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)

Based on assay type segmentation, cardiovascular imaging was predicted to show maximum market share in the year 2024

Based on end-use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Perfusion Radiology Market- Segmentation Analysis:

The Global Perfusion Radiology Market is segmented on the basis of Assay Type, Modality, End Use, and Region.

On the basis of assay type, the market is segregated into Cardiovascular Imaging, Brain Imaging, and Ventilation Imaging. In 2024, the market was dominated by the cardiovascular imaging category because cardiovascular diseases (CVDs) are becoming more and more common worldwide. Perfusion radiology has become more accurate and effective in identifying and treating cardiac problems due to developments in imaging technologies like computed tomography (CT) and magnetic resonance imaging (MRI). Furthermore, the need for cardiovascular imaging technologies has been fueled by rising healthcare costs as well as increased awareness of early diagnosis and treatment. Imaging systems have become essential in clinical practice due to the further improvement in diagnostic precision brought about by the incorporation of artificial intelligence (AI).

Based on modality, the market is divided into Magnetic Resonance Imaging (MRI), Nuclear Medicine, and Computed Tomography (CT). In 2024, the computed tomography (CT) category held a dominant market share because of its extensive availability, excellent diagnostic precision, and capacity to provide comprehensive cross-sectional images. They are crucial for managing strokes and evaluating cerebral blood flow, and developments such as low-dose CT are encouraging their use. Oncology, neurology, and cardiovascular care all make extensive use of techniques like arterial spin labelling (ASL) and dynamic contrast-enhanced (DCE) imaging. Magnetic resonance imaging (MRI) is becoming more and more popular due to its superior soft-tissue contrast, non-invasive capabilities, and radiation-free imaging.

Perfusion Radiology Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Perfusion Radiology. This leadership is ascribed to the region's strong investments in medical research, high prevalence of neurological and cardiovascular disorders, and well-established healthcare infrastructure. The United States primarily drives regional growth because of its large concentration of major market participants like Siemens and General Electric, as well as its robust adoption of advanced imaging technologies. Favourable reimbursement regulations further aid the growth of the perfusion radiology market in this area.

However, throughout the projected period, the Europe region is anticipated to see the fastest CAGR. Germany, France, and the UK are leading the way because of their sophisticated healthcare systems, widespread use of cutting-edge technologies, and government programs that encourage early disease detection. Perfusion radiology technologies are becoming more and more in demand as Europe's ageing population and the prevalence of chronic illnesses like cancer and stroke rise. The European Union's initiatives to promote medical research and international healthcare partnerships help fuel the perfusion radiology market expansion.

Perfusion Radiology Market- Competitive Landscape:

Several competitors are fighting for a larger share in the very competitive perfusion radiology market, such as GENERAL ELECTRIC COMPANY, Siemens Healthineers AG, Sonic Healthcare, InHealth Group, RadNet, Inc., and others. Pharmaceutical firms, software solution providers, and makers of medical imaging equipment are important industry participants. To improve their market position, these businesses concentrate on R&D, strategic alliances, mergers and acquisitions, and new product introductions. Product portfolio, technology developments, customer service, price policies, and brand reputation are important determinants of market competitiveness. In order to meet the unique requirements of healthcare providers, improve patient care, and increase overall operational efficiency, market participants work hard to deliver comprehensive perfusion radiology solutions. For instance, in May 2023, an unusual combination solution for PET myocardial perfusion-based imaging, AKURACY, was introduced by the Ion Beam Applications S.A. During the meeting of the European Association of Cardiovascular Imaging (EACVI) in Spain, this advanced technology was introduced. IBA, which is a member of EURONEXT, is a leader in the development of radiopharmaceutical production solutions and particle accelerator technologies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERFUSION RADIOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GENERAL ELECTRIC COMPANY
  • Siemens Healthineers AG
  • Sonic Healthcare
  • InHealth Group
  • RadNet, Inc.
  • Spectrum Health
  • Alliance HealthCare Services
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • RamSoft, Inc.
  • Others

GLOBAL PERFUSION RADIOLOGY MARKET, BY ASSAY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular Imaging
  • Brain Imaging
  • Ventilation Imaging

GLOBAL PERFUSION RADIOLOGY MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Magnetic Resonance Imaging (MRI)
  • Nuclear Medicine
  • Computed Tomography (CT)

GLOBAL PERFUSION RADIOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others

GLOBAL PERFUSION RADIOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Perfusion Radiology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Perfusion Radiology Market Snippet by Assay Type
    • 2.1.2. Perfusion Radiology Market Snippet by Modality
    • 2.1.3. Perfusion Radiology Market Snippet by End Use
    • 2.1.4. Perfusion Radiology Market Snippet by Country
    • 2.1.5. Perfusion Radiology Market Snippet by Region
  • 2.2. Competitive Insights

3. Perfusion Radiology Key Market Trends

  • 3.1. Perfusion Radiology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Perfusion Radiology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Perfusion Radiology Market Opportunities
  • 3.4. Perfusion Radiology Market Future Trends

4. Perfusion Radiology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Perfusion Radiology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Perfusion Radiology Market Landscape

  • 6.1. Perfusion Radiology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Perfusion Radiology Market - By Assay Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Assay Type, 2024 & 2032 (%)
    • 7.1.2. Cardiovascular Imaging
    • 7.1.3. Brain Imaging
    • 7.1.4. Ventilation Imaging

8. Perfusion Radiology Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 8.1.2. Magnetic Resonance Imaging (MRI)
    • 8.1.3. Nuclear Medicine
    • 8.1.4. Computed Tomography (CT)

9. Perfusion Radiology Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Others

10. Perfusion Radiology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Perfusion Radiology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Perfusion Radiology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Perfusion Radiology Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Perfusion Radiology Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Perfusion Radiology Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Perfusion Radiology Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GENERAL ELECTRIC COMPANY
    • 11.2.2. Siemens Healthineers AG
    • 11.2.3. Sonic Healthcare
    • 11.2.4. InHealth Group
    • 11.2.5. RadNet, Inc.
    • 11.2.6. Spectrum Health
    • 11.2.7. Alliance HealthCare Services
    • 11.2.8. Hologic Inc.
    • 11.2.9. Koninklijke Philips N.V.
    • 11.2.10. RamSoft, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us